2 Commas: The $multi-million exit show with Josh Comrie

John Bessey: His doctor said he was fine. The blood work said otherwise.

May 20, 2026·1h 6m
Episode Description from the Publisher

Most of us have no idea what's actually going on inside our body.John Bessey has been in the room for three major tech exits as CEO of Merkle (Davanti), head of revenue at Introgen, and on the executive team when Gen-I sold to Spark. He's also a certified metabolic and health coach who reckons most high-performers are flying blind on the things that actually matter and he's got the blood work to prove it.In this episode, John and I get into the overlap between building a high-performing business and building a body that doesn't quit before the game's over. He shares what actually worked when he stepped in as an external CEO and why most of those appointments fail, how Divanti's earn-out structure gave the founders real control through the sale, and the simple rituals he uses with executives to cut distraction and find the two or three things that will genuinely move the needle. On the health side, the four horsemen, why your GP's "you're fine" might be the most expensive thing you hear this year, and what John changed the day he stopped chasing biohacks and went back to basics.John's 55, thirteen kilos lighter than he was a decade ago, and building deliberately toward skiing Cardrona at 93. His book, Rituals of Impact, is available at ritualsofimpact.com (free shipping in NZ) and on Amazon worldwide.

Podzilla Summary coming soon

Sign up to get notified when the full AI-powered summary is ready.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.

Listen to This Episode

Get summaries like this every morning.

Free AI-powered recaps of 2 Commas: The $multi-million exit show with Josh Comrie and your other favorite podcasts, delivered to your inbox.

Get Free Summaries →

Free forever for up to 3 podcasts. No credit card required.